awards grant
- Characterization of the genomic and transcriptional landscape and role of tumor immune environment in multiple myeloma with extramedullary disease
- Establishing the role of Methylmalonic Acid in KRAS-mutated Lung Adenocarcinoma
- Zanubrutinib and Venetoclax as Initial Therapy for CLL with Obinutuzumab Consolidation in Patients with Minimal Residual Disease Positivity.